Scholar Rock Holding Corp
Research Scholar Rock Holding Corp (SRRK) on Bullrun: market cap USD 7.08B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSRRK
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 7.08B
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 109.90M
- Free cash flow-USD 70.31M
Valuation Snapshot
latest market cap is USD 7.08B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 378.00M | -USD 300.64M | n/a | -3.29 | USD 323.53M | USD 99.71M | USD 245.49M |
| FY2024 | USD 0 | -USD 246.00M | -USD 201.05M | n/a | -2.47 | USD 177.88M | USD 50.15M | USD 368.63M |
| FY2023 | n/a | -USD 166.00M | -USD 145.30M | n/a | -1.99 | USD 101.86M | USD 50.02M | USD 225.22M |
| FY2022 | USD 33.19M | -USD 134.50M | -USD 133.76M | n/a | -2.26 | USD 103.28M | USD 49.74M | USD 260.24M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 7.08B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 4.78B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 4.06B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 1.36B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 467.55M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 874.59M | n/a | n/a | n/a |
About Scholar Rock Holding Corp
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. The company's novel understanding of the molecular mechanisms of growth factor activation within the transforming growth factor beta (TGFß) superfamily has enabled the development of a proprietary platform.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Scholar Rock Holding Corp's market cap?
Scholar Rock Holding Corp's market capitalization is USD 7.08B.
What does Scholar Rock Holding Corp do?
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. The company's novel understanding of the molecular mechanisms of growth factor activation within the transforming growth factor beta (TGFß) superfamily has enabled the development of a proprietary platform. This platform is used for the development of monoclonal antibodies that locally and selectively target the precursor, or latent, forms of growth factors.